Collaborate Disseminate
A trio of new studies from the Centers for Disease Control and Prevention (CDC) offer the first real-world insights into the effectiveness of a third COVID-19 vaccine dose against the rapidly spreading Omicron variant of SARS-CoV-2. The research confir… Continue reading First US booster data shows 3rd dose crucial against Omicron
A new announcement from vaccine company Valneva indicates its experimental COVID-19 vaccine is effective at neutralizing the Omicron variant. The vaccine is at the tail-end of Phase 3 trials and is the first inactivated whole-virus vaccine to be triale… Continue reading New whole-virus COVID vaccine may be effective against Omicron
A meta-analysis looking at data from 12 vaccine trials has concluded up to three-quarters of adverse events reported following COVID-19 vaccination can be attributed to the placebo effect. The researchers call for improved public health communication t… Continue reading Most COVID vaccine side effects due to placebo effect, metastudy finds
A unique study led by researchers from the Harvard T.H. Chan School of Public Health has reported some of the first robust evidence to affirm multiple sclerosis (MS) is primarily caused by infection from the Epstein-Barr virus (EBV). Tracking more than… Continue reading More evidence a common virus is primary cause of multiple sclerosis
As mRNA innovations race forward researchers are now looking at ways to create skin cancer vaccines using the novel technology. A new study from Oregon State University proposes mRNA-induced production of a specific protein may prevent melanoma, while … Continue reading How mRNA vaccines could transform skin cancer treatment
More advances on the mRNA vaccine front this week as both Pfizer and Moderna move forward on new viral targets for future vaccines. Pfizer is turning its focus to shingles while Moderna has begun human trials for a mRNA vaccine against the Epstein-Barr… Continue reading mRNA vaccine makers set sights on shingles and the Epstein-Barr virus
Scientists at the Walter Reed Army Institute of Research are leading a massive project aimed at developing a universal coronavirus vaccine that can provide protection against all SARS-CoV-2 variants. A handful of newly published studies are reporting s… Continue reading US Army testing universal coronavirus vaccine against all variants
A new COVID-19 vaccine, developed by researchers from the Texas Children’s Hospital and Baylor College of Medicine, is being offered patent-free to vaccine manufacturers across the world. Human trials have shown the vaccine to be safe and effective, wi… Continue reading New patent-free COVID vaccine developed as “gift to the world”
Israel has begun the world’s first roll-out of a fourth COVID-19 vaccine dose. The program is initially focusing on patients with compromised immune systems, while a large study is underway testing the safety and efficacy of a fourth dose in several th… Continue reading Israel begins roll out of 4th COVID vaccine dose
An update from Pfizer on an ongoing clinical trial of its mRNA COVID-19 vaccine in children under the age of five is reporting two small doses do not generate effective immune responses in two to five year-olds. The trial is now being amended to add a … Continue reading Third mRNA COVID vaccine dose in young kids tested after two doses fail